about
Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study.Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study.Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.Gender difference in drug use in hospitalized elderly patients.Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia.Treatment of Spontaneous Bacterial Peritonitis.Use of non-selective beta blockers in cirrhosis: the evidence we need before closing (or not) the window.The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children.Coagulation and fibrosis: A potential non-negligible target of statins in chronic hepatitis.Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI Study.Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of AscitesGout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderlyInappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: results from the REPOSI registryTerlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trialHepatorenal syndrome type 1 and bacterial infection: a catastrophic association in patients with cirrhosis
P50
Q30837974-0A1D1076-2C03-46A8-9376-8194E5CC8FD3Q30906342-44384583-7BC3-4147-8F94-306D66B98023Q38336120-427E43FE-29DE-460D-A8CA-24AE51CA1AD1Q40697364-E7D9C94B-8F4C-4A9A-94BE-747C8E783EF4Q41033872-6431F5E5-6733-4BCE-AAB2-7432E0AAC83AQ41116135-8175D3D9-7907-487B-87D6-2201CD46EF16Q43165730-D83B5649-B35D-4893-8524-C57DCAA19170Q44794820-026FF1F0-AADF-46C2-A7D1-CF047D20EE19Q45873489-321259B2-9164-42AE-82AA-470A2CED9287Q48105632-FEBD27BE-4A93-4941-A369-AFE7DAAF0B4AQ56925081-CC9286F9-0555-42CB-A7AD-34313149F8A7Q58297769-6BDC4EA9-2AE2-4553-B41D-4CD7236D36BCQ58419002-7675586C-DFD6-4E19-B8D6-F4D2262168BCQ60198884-64C1AADD-BAF7-4B1D-A823-6F0A0CDC403DQ87099967-BF9F1CF3-385D-4B23-8659-F6DCDBAB8F63
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francesco Salerno
@ast
Francesco Salerno
@en
Francesco Salerno
@es
Francesco Salerno
@nl
Francesco Salerno
@sl
type
label
Francesco Salerno
@ast
Francesco Salerno
@en
Francesco Salerno
@es
Francesco Salerno
@nl
Francesco Salerno
@sl
prefLabel
Francesco Salerno
@ast
Francesco Salerno
@en
Francesco Salerno
@es
Francesco Salerno
@nl
Francesco Salerno
@sl
P106
P21
P31
P496
0000-0003-1978-6296